Your browser doesn't support javascript.
loading
Phase I study of a multitargeted recombinant Ad5 PSA/MUC-1/brachyury-based immunotherapy vaccine in patients with metastatic castration-resistant prostate cancer (mCRPC).
Bilusic, Marijo; McMahon, Sheri; Madan, Ravi A; Karzai, Fatima; Tsai, Yo-Ting; Donahue, Renee N; Palena, Claudia; Jochems, Caroline; Marté, Jennifer L; Floudas, Charalampos; Strauss, Julius; Redman, Jason; Abdul Sater, Houssein; Rabizadeh, Shahrooz; Soon-Shiong, Patrick; Schlom, Jeffrey; Gulley, James L.
Affiliation
  • Bilusic M; Genitourinary Malignancy Branch, National Cancer Institute, Bethesda, Maryland, USA marijo.bilusic@nih.gov.
  • McMahon S; Genitourinary Malignancy Branch, National Cancer Institute, Bethesda, Maryland, USA.
  • Madan RA; Genitourinary Malignancy Branch, National Cancer Institute, Bethesda, Maryland, USA.
  • Karzai F; Genitourinary Malignancy Branch, National Cancer Institute, Bethesda, Maryland, USA.
  • Tsai YT; Laboratory of Tumor Immunology and Biology, National Cancer Institute, Bethesda, Maryland, USA.
  • Donahue RN; Laboratory of Tumor Immunology and Biology, National Cancer Institute, Bethesda, Maryland, USA.
  • Palena C; Laboratory of Tumor Immunology and Biology, National Cancer Institute, Bethesda, Maryland, USA.
  • Jochems C; Laboratory of Tumor Immunology and Biology, National Cancer Institute, Bethesda, Maryland, USA.
  • Marté JL; Genitourinary Malignancy Branch, National Cancer Institute, Bethesda, Maryland, USA.
  • Floudas C; Genitourinary Malignancy Branch, National Cancer Institute, Bethesda, Maryland, USA.
  • Strauss J; Laboratory of Tumor Immunology and Biology, National Cancer Institute, Bethesda, Maryland, USA.
  • Redman J; Genitourinary Malignancy Branch, National Cancer Institute, Bethesda, Maryland, USA.
  • Abdul Sater H; Genitourinary Malignancy Branch, National Cancer Institute, Bethesda, Maryland, USA.
  • Rabizadeh S; ImmunityBio, Culver City, California, USA.
  • Soon-Shiong P; ImmunityBio, Culver City, California, USA.
  • Schlom J; Laboratory of Tumor Immunology and Biology, National Cancer Institute, Bethesda, Maryland, USA.
  • Gulley JL; Genitourinary Malignancy Branch, National Cancer Institute, Bethesda, Maryland, USA.
J Immunother Cancer ; 9(3)2021 03.
Article in En | MEDLINE | ID: mdl-33762322
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Kallikreins / Adenoviridae / Prostate-Specific Antigen / Vaccines, Combined / Mucin-1 / Cancer Vaccines / T-Box Domain Proteins / Fetal Proteins / Prostatic Neoplasms, Castration-Resistant Limits: Aged / Aged80 / Humans / Male / Middle aged Language: En Journal: J Immunother Cancer Year: 2021 Document type: Article Affiliation country:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Kallikreins / Adenoviridae / Prostate-Specific Antigen / Vaccines, Combined / Mucin-1 / Cancer Vaccines / T-Box Domain Proteins / Fetal Proteins / Prostatic Neoplasms, Castration-Resistant Limits: Aged / Aged80 / Humans / Male / Middle aged Language: En Journal: J Immunother Cancer Year: 2021 Document type: Article Affiliation country: